Inhaled Mannitol in CF

Trial Status: 
Current Trial - Enrolling

Purpose:

An 18 week study looking to have Cystic Fibrosis patients administer Dry Powder Mannitol or Placebo and study lung health.

Sponsor:

Pharmaxis

Principal Investigator: 

Cori Daines, MD

Contact Information:

Osmara Y. Molina de Rodriguez, MS

Cell: (520) 891-6767 or Office: (520) 626-3910

Principal Investigator: 
Research Area: 
Clinical and Population Research